Currently Open Funding Opportunity Announcements Relevant to Healthcare Delivery Research

This page includes currently open Funding Opportunity Announcements (FOAs) sponsored or co-sponsored by HDRP; other FOAs relevant to HDRP; and NIH and NCI Parent and Omnibus FOAs for investigator-initiated research. Descriptions of the most commonly used grant mechanisms can be found on the NIH Grants & Funding pagesExternal Web Site Policy and full FOA presentations are available on the FOA webinars page. If you have questions about a grant application, please contact the NCI Program Director listed on the FOA.

FOAs Sponsored or Co-Sponsored by HDRP

Announcement Title Announcement Number Expiration Date Program Contact FOA Videos/Webinars
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) PAR-21-081External Web Site Policy (R01 Clinical Trial Optional)
January 8, 2023 Brenda Adjei
240-276-6185
adjeiba@mail.nih.gov
Notice of Special Interest: Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways NOT-CA-21-019External Web Site Policy
February 5, 2023 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Notice of Special Interest: Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026External Web Site Policy May 8, 2023 Kate Castro
240-276-6834
kathleen.castro@nih.gov
video icon Watch WebinarExternal Web Site Policy
Notice of Special Interest: Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice NOT-OD-20-079External Web Site Policy May 8, 2023 Ashley Wilder-Smith
240-276-6714
smithas@mail.nih.gov
video icon Watch WebinarExternal Web Site Policy
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) PAR-20-179External Web Site Policy September 8, 2023 Bryan Kim
bryan.kim@nih.gov
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) PAR-20-180External Web Site Policy September 8, 2023 Bryan Kim
bryan.kim@nih.gov
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) PA-20-172External Web Site Policy September 8, 2023 Sallie Weaver
240-276-6254
sallie.weaver@nih.gov
Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) PAR-22-233External Web Site Policy November 2, 2023 Sallie Weaver
240-276-6254
sallie.weaver@nih.gov
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition NOT-HD-21-027External Web Site Policy January 8, 2024 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes NOT-CA-22-045External Web Site Policy March 1, 2024 Kate Castro
240-276-6834
kathleen.castro@nih.gov
video icon Watch Videos:
View/Dowload FAQs (PDF, 171 KB)
Notice of Special Interest (NOSI): New Information Technology-Enabled Care Delivery Models to Improve Depression Care in Cancer NOT-CA-21-085External Web Site Policy March 8, 2024 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Notice of Special Interest (NOSI): Telehealth in Cancer Care NOT-CA-21-043External Web Site Policy March 8, 2024 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)(Reissue of PAR-18-869External Web Site Policy) PAR-21-190External Web Site Policy March 8, 2024 Scott Rogers
240-276-6932
rogerssc@mail.nih.gov
video icon Watch WebinarExternal Web Site Policy
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) PAR-22-072External Web Site Policy May 8, 2024

Roxanne Jensen
roxanne.jensen@nih.gov

Janeth Sanchez
janeth.sanchez@nih.gov

Notice of Special Interest: Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health NOT-OD-21-100External Web Site Policy June 8, 2024 Janet de Moor
240-276-6806
janet.demoor@nih.gov
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) PAR-22-092External Web Site Policy September 8, 2024 Sallie Weaver
240-276-6254
sallie.weaver@nih.gov
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) PAR-21-341External Web Site Policy October 9, 2024 Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors NOT-CA-22-029External Web Site Policy October 9, 2024 Veronica Chollette
cholletv@mail.nih.gov
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-22-014External Web Site Policy October 9, 2024

Sallie Weaver
240-276-6254
sallie.weaver@nih.gov

Veronica Chollette
cholletv@mail.nih.gov

video icon Watch WebinarExternal Web Site Policy
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) PAR-22-064External Web Site Policy January 8, 2025

Sallie Weaver
240-276-6254
sallie.weaver@nih.gov

Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan NOT-OD-22-178External Web Site Policy May 8, 2025

Elizabeth Sarma
240-276-7434
elizabeth.sarma@nih.gov

Other FOAs Relevant to HDRP

Announcement Title Announcement Number Expiration Date Program Contact
Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) RFA-CA-22-052External Web Site Policy February 16, 2023

Kelly K FilipskiExternal Web Site Policy
240-276-6841
Kelly.Filipski@nih.gov

Andrew N. FreedmanExternal Web Site Policy
240-276-6697
andrew_freedman@nih.gov

Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed) RFA-CA-22-053External Web Site Policy February 16, 2023

Kelly K FilipskiExternal Web Site Policy
240-276-6841
Kelly.Filipski@nih.gov

Andrew N. FreedmanExternal Web Site Policy
240-276-6697
andrew_freedman@nih.gov

Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan NOT-OD-22-178External Web Site Policy May 8, 2025 Elizabeth Sarma
(240) 276-7434
elizabeth.sarma@nih.gov

NIH and NCI Parent and Omnibus FOAs for Investigator-Initiated Research

Announcement Title Announcement Number Expiration Date
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-20-185External Web Site Policy May 8, 2023
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-21-035External Web Site Policy January 8, 2024

Visit the NIH Grants & Funding websiteExternal Web Site Policy for a full list of all NIH parent announcements.

Visit the DCCPS Archive of Funding OpportunitiesExternal Web Site Policy for a full list of HDRP archived funding opportunities.

Last Updated: 08 Dec, 2022